ad-reic/dkk-3
Gene therapyexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT01197209)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Dickkopf-related protein 3Supplementation
supplementation - DKK3
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad5-sge-reic/dkk3
- ad-reic/dkk-3
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01931046 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2013 | Baylor University, Momotaro-Gene Inc., Pacific-Link Consulting, University of California, San Diego |
| NCT01197209 | Phase 1 | Sep 1, 2010 | Icahn School of Medicine at Mount Sinai, Momotaro-Gene Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Momotaro-Gene Inc. | For profit | 2 | 2 | 2 | 2010 |
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Pacific-Link Consulting | For profit | 1 | 0 | 1 | 2013 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2013 |
5 organizations
Page 1 / 1